Ampholipad - Systemic Fungal Infections Drug

Ampholipad is a generic of AmBisome, a lipid-encapsulated version of the antifungal drug amphotericin B. Ampholipad successfully demonstrated bioequivalence to AmBisome in all three forms and in both large and small batches, making it the first and only drug to have achieved such a feat. Scaled-up production of Ampholipad™ can surpass a million vials each year, at a capacity capable of meeting increasing global demands.